SCHEMBL9124580

SCHEMBL9124580

O=Cc1ccccc1C(c1ccc(OCc2ccccc2)cc1)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ GSK3B P49841 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ MAOA P21397 2/20 0.46
▸ MAOB P27338 2/20 0.46
▸ IDH1 O75874 1/20 0.45
▸ NR4A1 P22736 1/20 0.45
▸ NR4A2 P43354 1/20 0.45
▸ NR4A3 Q92570 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124733 0.80 ALDH1A1 (0.38) LMNACYP1A2CYP2C19GAAMAPT
SCHEMBL2032112 0.79 LMNA (0.64) BCHELMNACYP1A2PTGS1SLC6A2
SCHEMBL824976 0.79 LMNA (0.64) BCHELMNACYP1A2PTGS1SLC6A2
SCHEMBL4432541 0.78 KMT2A (0.50) LMNASLC6A2SLC6A3GAASMN1; SMN2
SCHEMBL824953 0.76 LMNA (0.64) BCHELMNACYP1A2PTGS1SLC6A2
SCHEMBL9121818 0.75 LMNA (0.51) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL7680291 0.75 MAOA (0.53) BCHEGSK3BBACE1MAOAMAOB
SCHEMBL4817844 0.74 MAOB (0.52) MAOAMAOBMAPTRAB9AALOX5
SCHEMBL8505924 0.74 LMNA (0.53) BCHELMNACYP1A2PTGS1SLC6A2
SCHEMBL8505922 0.74 LMNA (0.53) BCHELMNACYP1A2PTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5413997-A For treatment of osteoporosis KYOWA HAKKO KOGYO CO., LTD. (JP) 1995-05-09 — — US disclosed
EP-0395093-B1 TRIPHENYLMETHANE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-09-01 — — EP disclosed
US-5112867-A Osteoporosis Treatment KYOWA HAKKO GOGYO CO., LTD. (JP) 1992-05-12 — — US disclosed
EP-0395093-A1 Triphenylmethane derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1990-10-31 — — EP disclosed
Send feedback